Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06802185Phase 1Completed
Phase 1, randomised, open-label trial of ibuprofen and acetaminophen in pain (4 arms), sponsored by Haleon. Primary endpoints: Maximum Observed Post-dose Concentration at 24 hours, Area Under the Plasma Concentration Versus Time Curve from time 0 to last measurable time point at 24 hours and 1 more. Started Jan 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06802185.